CLDN2 expression increased cellular proliferation, anchorage-independent growth and tumor growth in vivo, potentially via the epidermal growth factor receptor (EGFR) transactivation, a key regulator of colorectal carcinogenesis [35]. Here, EGFR is linked to neoplasm.